PMN (Lox-1- PMN) and PMN-MDSC (Lox-1+ PMN) are nearly impossible to distinguish through external features. PMN cells from a patient with head and neck cancer. Scale bars, 20 μm. This material relates ...
Povetacicept substantially reduced proteinuria with stable eGFR over 48 weeks in patients with IgAN or pMN, according to interim data from the phase 1/2 RUBY-3 trial. Povetacicept safely reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback